APA

Chandran P., Kavalakatt A., Malarvizhi G. L., Vasanthakumari D. R. V. N., Retnakumari A. P., Sidharthan N., Pavithran K., Nair S. & Koyakutty M. (20141230). Epigenetics targeted protein-vorinostat nanomedicine inducing apoptosis in heterogeneous population of primary acute myeloid leukemia cells including refractory and relapsed cases. : Nanomedicine : nanotechnology, biology, and medicine.

Chicago

Chandran Parwathy, Kavalakatt Anu, Malarvizhi Giridharan Loghanathan, Vasanthakumari Divya Rani Vikraman Nair, Retnakumari Archana Payickattu, Sidharthan Neeraj, Pavithran Keechilat, Nair Shantikumar and Koyakutty Manzoor. 20141230. Epigenetics targeted protein-vorinostat nanomedicine inducing apoptosis in heterogeneous population of primary acute myeloid leukemia cells including refractory and relapsed cases. : Nanomedicine : nanotechnology, biology, and medicine.

Harvard

Chandran P., Kavalakatt A., Malarvizhi G. L., Vasanthakumari D. R. V. N., Retnakumari A. P., Sidharthan N., Pavithran K., Nair S. and Koyakutty M. (20141230). Epigenetics targeted protein-vorinostat nanomedicine inducing apoptosis in heterogeneous population of primary acute myeloid leukemia cells including refractory and relapsed cases. : Nanomedicine : nanotechnology, biology, and medicine.

MLA

Chandran Parwathy, Kavalakatt Anu, Malarvizhi Giridharan Loghanathan, Vasanthakumari Divya Rani Vikraman Nair, Retnakumari Archana Payickattu, Sidharthan Neeraj, Pavithran Keechilat, Nair Shantikumar and Koyakutty Manzoor. Epigenetics targeted protein-vorinostat nanomedicine inducing apoptosis in heterogeneous population of primary acute myeloid leukemia cells including refractory and relapsed cases. : Nanomedicine : nanotechnology, biology, and medicine. 20141230.